ENDONOVO THERAPEUTICS, INC. — Form D

ENDONOVO THERAPEUTICS, INC. of WOODLAND HILLS, CA, a company, filed a Form D exempt-offering notice with the SEC on 2019-11-22. The offering totals $2.0M, of which $225K was reported sold. Industry: Biotechnology.

Offering

Filed: 2019-11-22
Form: D
Accession: 0001528172-19-000001
Industry: Biotechnology
Exemptions: 06c
Total offering: $2.0M
Amount sold: $225K
Remaining: $1.8M
Minimum investment: $25K
Investors: 4
Date of first sale: 2019-10-31
Security types: equity
Revenue range: $1 - $1,000,000
SEC file number: 021-354045

Issuer

Name: ENDONOVO THERAPEUTICS, INC.
CIK: 0001528172
Entity type: Corporation
Jurisdiction: DELAWARE
Incorporated: 2011
Address: 6320 CANOGA AVENUE, WOODLAND HILLS, CA, 91367
Phone: (800) 489-4774

Officers, directors & promoters (5)

Name	Role	Location
Collier Collier	Director	Woodland Hills, CA
Collier Collier	Executive Officer	Woodland Hills, CA
Michael Mann	Executive Officer	Dallas, TX
Alan Collier	Director	Woodland Hills, CA
Alan Collier	Executive Officer	Woodland Hills, CA

Other filings by this issuer (8)

Filed	Form	Offering	Sold
2017-12-29	D	$8.0M	$700K
2016-02-19	D	$5.0M	$211K
2014-12-09	D	$500K	$105K
2014-12-03	D	$25K	$13K
2014-12-03	D/A	$500K	$50K
2014-09-05	D	$500K	$25K
2014-08-11	D/A	$500K	$483K
2013-11-15	D	$500K	$10K

More